Incorporation of rituximab and liposomal doxorubicin into CODOX-m/IVAC for HIV-negative and HIV-positive adult patients (pts) with untreated Burkitt's lymphoma (BL): Preliminary results of a multicenter phase II study

被引：1

作者：

Gregory, S. A.

Barr, P. M.

Nabhan, C.

Nukala, A.

Gallot, L.

Larsen, A.

Moll, M. Z.

Smith, S. E.

Gordon, L. I.

Evens, A. M.

机构：

[1] Rush Univ, Med Ctr, Chicago, IL 60612 USA

[2] Case Western Reserve Univ, Sch Med, Cleveland, OH USA

[3] Oncol Specialists SC, Park Ridge, IL USA

[4] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

[5] Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA

[6] Northwestern Univ, Div Hematol Oncol, Feinberg Sch Med, Chicago, IL 60611 USA

[7] Loyola Univ, Med Ctr, Maywood, IL 60153 USA

来源：

关键词：

D O I：

10.1200/jco.2010.28.15_suppl.8033

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8033

引用

页数：1